Aberrant signaling in disease

Signaling pathways that control embryogenesis are frequently deregulated in human cancers. How do acquired mutations in signaling pathway components lead to disease onset, and how can treatment therapies be tailored to patients?

We study models of acute myeloid leukemia (AML) patients using zebrafish mutant systems.